[What is secured in the therapy of chronic inflammatory colonic diseases?].
D000287:Administration, Topical; D000562:Amebiasis / Q000188:drug therapy; D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use; D002908:Chronic Disease; D003092:Colitis / Q000601:surgery / Q000628:therapy; D003093:Colitis, Ulcerative / Q000628:therapy; D003108:Colonic Diseases / Q000178:diet therapy / Q000628:therapy*; D003424:Crohn Disease / Q000601:surgery / Q000628:therapy; D004239:Diverticulitis, Colonic / Q000628:therapy; D006801:Humans; D007249:Inflammation; D008795:Metronidazole / Q000627:therapeutic use; D010288:Parenteral Nutrition; D013256:Steroids / Q000009:adverse effects / Q000627:therapeutic use; D012460:Sulfasalazine / Q000009:adverse effects / Q000627:therapeutic use
D013256:Steroids; D008795:Metronidazole; D012460:Sulfasalazine; D001379:Azathioprine
Was ist gesichert in der Therapie chronisch-entzündlicher Dickdarmerkrankungen?